This is a demo store. No orders will be fulfilled.

Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1®‡ and Limosilactobacillus reuteri RC-14®‡, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.*
- Probiotic for Women with 25+ Years of Research That Supports Benefits For Vaginal and Urinary Tract Health*
- Clinically-Documented Benefits
- More Than 20 Studies Demonstrating Safety and Efficacy*
- Patented Lactobacilli Strains: GR-1® and RC-14®
- Prevention Magazine: Top 10 Breakthrough ’07
Serving Size: 1 Capsule
Servings Per Container: 60
- Proprietary Probiotic Blend 134 mg (5 Billion CFU) ††
- Lacticaseibacillus rhamnosus GR-1® ††
- Limosilactobacillus reuteri RC-14® ††
- †† Daily Value (DV) not established.
Other Ingredients: Maltodextrin (non-GMO source), vegetarian capsule (hydroxypropylmethylcellulose, titanium dioxide), cellulose and magnesium stearate (vegetable source).
No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.
Free of major allergens.
For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.
If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
Keep refrigerated.
Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition; if adverse reactions occur, discontinue use.
Keep out of reach of children.
Validate your login
Sign In
Create New Account